この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1997/11/141 分で読めます
Iatric Corp.; Revocation of Product License for Coccidioidin, USP (BioCox)
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing the revocation of the biological product license issued to Iatric Corp., Tempe, AZ, for the manufacture of Coccidioidin, USP (BioCox). In a letter to FDA dated May 13, 1997, Iatric Corp. voluntarily requested revocation of its product license for Coccidioidin, USP (BioCox). In a letter dated June 25, 1997, FDA informed the firm that its product license for Coccidioidin, USP (BioCox) was revoked.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →